{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:27:53Z","timestamp":1772119673507,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10792-021-02174-5","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T22:02:33Z","timestamp":1641247353000},"page":"1771-1780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["When to start tacrolimus ointment for vernal keratoconjunctivitis? A proposed treatment protocol"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-8574","authenticated-orcid":false,"given":"Roee","family":"Arnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Rozen-Knisbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Yahalomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Stanescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Niazov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Sharabi\u2013Nov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Mostovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"2174_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/OPTH.S129552","volume":"12","author":"H Addis","year":"2018","unstructured":"Addis H, Jeng BH (2018) Vernal keratoconjunctivitis. Clin Ophthalmol 12:119\u2013123","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"2174_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4103\/0301-4738.119431","volume":"61","author":"U Saboo","year":"2013","unstructured":"Saboo U, Sangwan V, Jain M, Reddy J (2013) Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India. Indian J Ophthalmol 61(9):486","journal-title":"Indian J Ophthalmol"},{"key":"2174_CR3","first-page":"3850172","volume":"2018","author":"M Nebbioso","year":"2018","unstructured":"Nebbioso M, Iannaccone A, Duse M, Aventaggiato M, Bruscolini A, Zicari AM (2018) Vascular endothelial growth factor (VEGF) serological and lacrimal signaling in patients affected by vernal keratoconjunctivitis (VKC). J Ophthalmol 2018:3850172","journal-title":"J Ophthalmol"},{"key":"2174_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013298","author":"SE Kim","year":"2019","unstructured":"Kim SE, Quartilho A, Larkin F, Hingorani M, Tuft S, Dahlmann-Noor A (2019) Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013298","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2174_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.eye.6700675","volume":"18","author":"S Bonini","year":"2004","unstructured":"Bonini S, Coassin M, Aronni S, Lambiase A (2004) Vernal keratoconjunctivitis. Eye 18(4):345\u2013351","journal-title":"Eye"},{"issue":"2","key":"2174_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40123-013-0019-y","volume":"2","author":"A Leonardi","year":"2013","unstructured":"Leonardi A (2013) Management of vernal keratoconjunctivitis. Ophthalmol Ther 2(2):73\u201388","journal-title":"Ophthalmol Ther"},{"key":"2174_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2147\/OPTH.S181811","volume":"13","author":"M Nebbioso","year":"2019","unstructured":"Nebbioso M, Alisi L, Giovannetti F, Armentano M, Lambiase A (2019) Eye drop emulsion containing 0.1% cyclosporin (1 mg\/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy. Clin Ophthalmol 13:1147\u201355","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"2174_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","volume":"126","author":"A Leonardi","year":"2019","unstructured":"Leonardi A, Doan S, Amrane M, Ismail D, Montero J, N\u00e9meth J et al (2019) A randomized, controlled trial of cyclosporine a cationic emulsion in pediatric vernal keratoconjunctivitis. Ophthalmology 126(5):671\u2013681","journal-title":"Ophthalmology"},{"issue":"8","key":"2174_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","volume":"98","author":"A Fukushima","year":"2014","unstructured":"Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Kumagai N et al (2014) Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol 98(8):1023\u20137","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"2174_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4103\/0301-4738.119431","volume":"61","author":"US Saboo","year":"2013","unstructured":"Saboo US, Jain M, Reddy JC, Sangwan VS (2013) Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India. Indian J Ophthalmol 61(9):486\u2013489","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"2174_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/0301-4738.179727","volume":"64","author":"NS Gokhale","year":"2016","unstructured":"Gokhale NS (2016) Systematic approach to managing vernal keratoconjunctivitis in clinical practice: severity grading system and a treatment algorithm. Indian J Ophthalmol 64(2):145","journal-title":"Indian J Ophthalmol"},{"key":"2174_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0656-4","author":"AM Zicari","year":"2019","unstructured":"Zicari AM, Capata G, Nebbioso M, De Castro G, Midulla F, Leonardi L et al (2019) Vernal keratoconjunctivitis: an update focused on clinical grading system. Ital J Pediatr BioMed Central Ltd. https:\/\/doi.org\/10.1186\/s13052-019-0656-4","journal-title":"Ital J Pediatr BioMed Central Ltd"},{"issue":"11","key":"2174_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1097\/ICO.0000000000000918","volume":"35","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Agrawal D (2016) Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis. Cornea 35(11):1444\u20131448","journal-title":"Cornea"},{"issue":"9","key":"2174_CR14","first-page":"813","volume":"5","author":"KA McVeigh","year":"2015","unstructured":"McVeigh KA, Vakros G (2015) The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol 5(9):813\u2013819","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"2174_CR15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2009.11.043","volume":"117","author":"M Sacchetti","year":"2010","unstructured":"Sacchetti M, Lambiase A, Mantelli F, Deligianni V, Leonardi A, Bonini S (2010) Tailored approach to the treatment of vernal keratoconjunctivitis. Ophthalmology 117(7):1294\u20139","journal-title":"Ophthalmology"},{"issue":"1","key":"2174_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2340\/00015555-1188","volume":"92","author":"AL Su\u00e1rez","year":"2012","unstructured":"Su\u00e1rez AL, Feramisco JD, Koo J, Steinhoff M (2012) Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Dermato-Venereologica 92(1):7\u201315","journal-title":"Acta Dermato-Venereologica"},{"issue":"10","key":"2174_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/CLEP.S146442","volume":"13","author":"J Castellsague","year":"2018","unstructured":"Castellsague J, Kuiper JG, Potteg\u00e5rd A, Berglind IA, Dedman D, Gutierrez L et al (2018) A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European longitudinal lymphoma and skin cancer evaluation \u2013 JOELLE study). Clin Epidemiol 13(10):299\u2013310","journal-title":"Clin Epidemiol"},{"issue":"6","key":"2174_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","volume":"72","author":"L Legendre","year":"2015","unstructured":"Legendre L, Barnetche T, Mazereeuw-Hautier J, Meyer N, Murrell D, Paul C (2015) Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J Am Acad Dermatol 72(6):992\u20131002","journal-title":"J Am Acad Dermatol"},{"key":"2174_CR19","doi-asserted-by":"crossref","unstructured":"Cury Martins J, Martins C, Aoki V, Gois AFT, Ishii HA, da Silva EMK (2015) Topical tacrolimus for atopic dermatitis. Vol. 2015, Cochrane Database of Systematic Reviews. Wiley","DOI":"10.1002\/14651858.CD009864.pub2"},{"issue":"3","key":"2174_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2133.2011.10363.x","volume":"165","author":"P Tennis","year":"2011","unstructured":"Tennis P, Gelfand JM, Rothman KJ (2011) Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165(3):465\u201373","journal-title":"Br J Dermatol"},{"key":"2174_CR21","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1345\/aph.1M278","volume":"43","author":"RL Hui","year":"2009","unstructured":"Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M (2009) Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother 43:1956\u20131963","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2174_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40257-013-0020-1","volume":"14","author":"EC Siegfried","year":"2013","unstructured":"Siegfried EC, Jaworski JC, Hebert AA (2013) Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol 14(3):163\u201378","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2174_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ajo.2013.10.006","volume":"157","author":"AM Al-Amri","year":"2014","unstructured":"Al-Amri AM (2014) Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. Am J Ophthalmol 157(2):280\u2013286","journal-title":"Am J Ophthalmol"},{"key":"2174_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/pgmj.52.612.634","volume":"52","author":"WJ Dinning","year":"1976","unstructured":"Dinning WJ (1976) Steroids and the eye-indications and complications. Postgrad Med J 52:634\u2013638","journal-title":"Postgrad Med J"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-02174-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T09:17:40Z","timestamp":1653988660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-02174-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2174"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-02174-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-694131\/v1","asserted-by":"object"}]},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was received by Helsinki committee of Assuta-Samson Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}